Glenmark Pharma climbs nearly 3 per cent on receiving USFDA approval
Glenmark Pharma climbs nearly 3 per cent on receiving USFDA approval

Glenmark Pharma climbs nearly 3 per cent on receiving USFDA approval

Chinmayee D Article rating: 4.8

Glenmark Pharmaceuticals Limited announced on Wednesday that the company has received final approval from United States Food & Drug Administration (USFDA). Reacting to the news, its share rose nearly 2 per cent on BSE.

Stocks that are likely to record significant movement on bourses today
Stocks that are likely to record significant movement on bourses today

Stocks that are likely to record significant movement on bourses today

Karan Dsij Article rating: 4.4

Tata Consumer Products Ltd:  The company has entered into share purchase agreements (SPAs) and a share purchase & investment agreement (SPIA) with the existing promoters and shareholders of Kottaram Agro Foods Private Limited.

Nifty: Bulls in full control
Nifty: Bulls in full control

Nifty: Bulls in full control

Karan Dsij Article rating: 4.5

High spirits continued for the second straight day on Tuesday on the back of growth orient announcements in the Union Budget 2021. Nifty opened with a gap-up and went onto touch the high of 14,731 in the morning session. However, soon, opening gains pared and the index traded in a narrow range to settle with gains of 2.57 per cent at 14,648 levels.

Good news for 75-plus retirees
Good news for 75-plus retirees

Good news for 75-plus retirees

Henil Shah Article rating: 5.0

As per the new mandate, senior citizens aged 75 & above are not required to file income tax returns, subject to conditions. Read onto find out more.

Power Grid Corporation rises nearly 3 per cent on winning new order
Power Grid Corporation rises nearly 3 per cent on winning new order

Power Grid Corporation rises nearly 3 per cent on winning new order

Ganesh V Article rating: 4.3

Power Grid Corporation of India Limited made the announcement on Monday after the market hours that it has been declared as the successful bidder under tariff-based competitive bidding for establishing transmission system for “transmission system strengthening scheme for the evacuation of power from solar energy zones in Rajasthan (8.1 GW) under Phase II – Part C” on the build, own operate & maintain (BOOM) basis. 

REIT analysis: Brookfield India REIT
REIT analysis: Brookfield India REIT

REIT analysis: Brookfield India REIT

Henil Shah Article rating: 3.3

Brookfield India REIT is approaching the capital market to raise Rs 3,800 crore. Read onto find out if you should subscribe to the issue.

Dr Reddys Laboratories share climbs 2 per cent on new tablet launch
Dr Reddys Laboratories share climbs 2 per cent on new tablet launch

Dr Reddys Laboratories share climbs 2 per cent on new tablet launch

Abhinav Lahoti Article rating: 4.5

Dr Reddy’s Laboratories today announced the launch of Vigabatrin tablets USP, 500 mg, a therapeutic equivalent generic version of Sabril® (Vigabatrin) tablets, USP, approved by United States Food & Drug Administration (USFDA).

RSS
First18511852185318541856185818591860Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR